Skip to content

JACS JACS Equity issuance costs

Equity issuance costs at other companies

JAC
Jackson Acquisition Company IIJACS
$81.31K
Redwire logo
RedwireRDW
$437.25K
National Health Investors logo
National Health InvestorsNHI
$0-100%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$65.65K+260%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+119%
Curbline Properties logo
Curbline PropertiesCURB
$671K

Other financials

Income statement

See full
Operating income-$168.3K+18.4%
Net income$2.0M-11.6%
EPS (diluted)$0.07-12.5%

Balance sheet

See full
Cash & equivalents$393.5K-48.0%
Total equity$52.5K-91.0%
Total assets$245.2M+3.8%

Cash flow

See full
Operating cash flow-$128.3K+33.7%

Valuation

See full
Market cap$314.69M+3.3%
P/E35.5×

Returns & leverage

See full
Return on equity2,785.2%
Current ratio1.1×-1.2×

Where this comes from

Reported directly by JACS in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.

The official record: JACS’s 10-K, filed March 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about JACS's equity issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JACS's equity issuance costs?
JACS (JACS) reported equity issuance costs of $81.31K in Q4 2024.
What does equity issuance costs mean?
Represents the costs directly attributable to the issuance of equity, which are deducted from additional paid-in capital rather than expensed through the income statement. This metric helps in assessing the total cost of capital raising activities.